Michael Atkins
Net worth: 6 489 $ as of 31/05/2026
Net worth: 6 489 $ as of 31/05/2026
Michael B. Atkins currently holds the positions of Director at Melanoma Research Foundation, Independent Director at Werewolf Therapeutics, Inc. since 2024, President at Society For Immunotherapy of Cancer, and Professor at Harvard Medical School since 2002.
Dr. Atkins completed undergraduate education at Tufts University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2025 | 14,419 ( 0.03% ) | 6 489 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Director/Board Member | 04/01/2024 |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Director/Board Member | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Commercial Services |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions